Political contribution deductions require genuine transactions; banking records and party registration alone cannot defeat evidence of accommodation e...
Post-death GST liability permits fresh proceedings against legal representatives, while discontinued-business recovery remains limited to the inherite...
Non-confirmation of FEMA seizure prevents adjudicators from overriding pending appellate findings on recorded reasons and suspected foreign asset hold...
DGFT has withdrawn Para 2.76 of Handbook of Procedures 2023 (formerly Para 2.90A of HBP 2015-2020) regarding Track and Trace system for export of drug formulations, exercising powers under Paragraphs 1.03 and 2.04 of Foreign Trade Policy 2023. The responsibility for implementing authentication systems for exported drug formulations now transfers to Ministry of Health and Family Welfare, to be administered under Drug Rules 1945. The withdrawal takes immediate effect, marking a significant shift in regulatory oversight of pharmaceutical exports from trade authorities to healthcare regulators.
DGFT has withdrawn Para 2.76 of Handbook of Procedures 2023 (formerly Para 2.90A of HBP 2015-2020) regarding Track and Trace system for export of drug formulations, exercising powers under Paragraphs 1.03 and 2.04 of Foreign Trade Policy 2023. The responsibility for implementing authentication systems for exported drug formulations now transfers to Ministry of Health and Family Welfare, to be administered under Drug Rules 1945. The withdrawal takes immediate effect, marking a significant shift in regulatory oversight of pharmaceutical exports from trade authorities to healthcare regulators.
Note: It is a system-generated summary and is for quick reference only.